Promethazine for Allergies
Promethazine is FDA-approved and effective for treating various allergic conditions including perennial and seasonal allergic rhinitis, allergic conjunctivitis, urticaria, and angioedema, but should be reserved for short-term use due to significant safety concerns including sedation, respiratory depression, and tissue damage risks with parenteral administration. 1
FDA-Approved Allergic Indications
Promethazine is specifically indicated for: 1
- Perennial and seasonal allergic rhinitis
- Vasomotor rhinitis
- Allergic conjunctivitis due to inhalant allergens and foods
- Mild, uncomplicated allergic skin manifestations including urticaria and angioedema
- Amelioration of allergic reactions to blood or plasma
- Dermographism
- Anaphylactic reactions as adjunctive therapy to epinephrine after acute manifestations are controlled
Mechanism of Action in Allergies
Promethazine works through competitive histamine H1-receptor antagonism, blocking H1 receptors and inhibiting most pharmacologic effects of histamine, which accounts for its antihistamine properties. 2 This mechanism makes it effective for allergic symptoms, though it also produces significant anticholinergic and alpha-adrenergic blocking effects that contribute to its side effect profile. 2
Dosing for Allergic Conditions
For adults: 1
- Standard dose: 25 mg taken before bedtime
- Alternative regimen: 12.5 mg before meals and at bedtime if necessary
- Maintenance: 25 mg at bedtime or 6.25-12.5 mg three times daily after symptom control
For children over 2 years: 1
- Dosage should be adjusted to the smallest amount adequate to relieve symptoms
- 12.5-25 mg doses may be used
Critical contraindication: Promethazine is absolutely contraindicated in children under 2 years of age. 1
Pharmacokinetics Relevant to Allergy Treatment
- Onset of action: Within 20 minutes after oral administration 2, 3
- Duration: 4-6 hours, though effects may persist up to 12 hours 2, 3
- Half-life: 9-16 hours 2, 3
Safety Limitations for Chronic Allergy Management
Promethazine is inappropriate for chronic or long-term allergy management due to several critical safety concerns: 3
- Extrapyramidal effects including neuroleptic malignant syndrome can occur, making chronic use dangerous 3
- Significant sedation is particularly problematic with repeated dosing or when combined with opioids 3
- Respiratory depression risk increases with cumulative dosing 3
- Tissue damage risks (thrombophlebitis, tissue necrosis, gangrene) with IV administration argue against repeated courses 3
Important Clinical Caveats
Seizure threshold lowering: Promethazine can lower seizure threshold, and patients with known seizure disorders should be maintained on their antiepileptic medications when promethazine must be used. 2 Monitoring for signs of increased seizure activity is crucial in these patients. 2
Pediatric safety concerns: Despite its FDA approval for children over 2 years, promethazine has been reported to cause significant sedation, agitation, hallucinations, seizures, dystonic reactions, and possibly apparent life-threatening events. 4 Children under 2 years are most vulnerable to these adverse reactions. 4
Drug interaction with CNS depressants: Promethazine exhibits enhanced sedative effects when combined with benzodiazepines, opioids, and other CNS depressants. 2
Parenteral administration risks: If IV administration is necessary (rarely for allergies), it must be infused slowly (≤25 mg/min) to minimize hypotension risk, and extreme caution is required due to risks of extravasation, tissue necrosis, and inadvertent intra-arterial injection. 3, 5
Practical Recommendation
For acute allergic symptoms in adults and children over 2 years, promethazine can be used at standard doses (25 mg for adults, 12.5-25 mg for children) for short-term relief, but newer, safer antihistamines without sedation and extrapyramidal risks should be strongly preferred for routine allergy management. 1 Reserve promethazine for situations where other antihistamines have failed or are unavailable, and always use the lowest effective dose for the shortest duration possible. 1